Primary Myelofibrosis
Showing NaN - NaN of 19
Thrombocythemia, Essential, Primary Myelofibrosis Trial in Worldwide (Bomedemstat)
Enrolling by invitation
- Thrombocythemia, Essential
- Primary Myelofibrosis
-
Miami, Florida
- +18 more
Jan 30, 2023
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, other, radiation)
Active, not recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Allogeneic Hematopoietic Stem Cell Transplantation
- +11 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 10, 2023
Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide
Recruiting
- Primary Myelofibrosis
- +2 more
- Pacritinib
- Physician's Choice medications
-
Birmingham, Alabama
- +151 more
Aug 22, 2022
Acute Myeloid Leukemia, Essential Thrombocythemia, Myelodysplastic Syndrome Trial in Seattle (Decitabine, Ruxolitinib,
Recruiting
- Acute Myeloid Leukemia
- +8 more
- Decitabine
- +3 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 18, 2022
Primary Myelofibrosis, Secondary Myelofibrosis Trial in Seattle (procedure, drug, radiation)
Recruiting
- Primary Myelofibrosis
- Secondary Myelofibrosis
- Allogeneic Hematopoietic Stem Cell Transplantation
- +9 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jun 21, 2022
Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Post- Essential Thrombocythemia Myelofibrosis Trial in Worldwide
Completed
- Primary Myelofibrosis
- +2 more
-
Phoenix, Arizona
- +61 more
May 5, 2022
Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Post-essential Thrombocythemia Myelofibrosis Trial in Worldwide
Terminated
- Primary Myelofibrosis
- +2 more
- Pacritinib
- Best Available Therapy
-
Scottsdale, Arizona
- +121 more
Oct 21, 2021
Connect® Myeloid Disease Registry
Recruiting
- Primary Myelofibrosis
- +2 more
-
Huntsville, Alabama
- +228 more
Mar 30, 2021
Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Completed
- Hematopoietic/Lymphoid Cancer
- +135 more
- beclomethasone dipropionate
- +4 more
-
Hackensack, New Jersey
- +1 more
Feb 1, 2021
Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in
Completed
- Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative
- +13 more
- Cyclosporine
- +6 more
-
Salt Lake City, Utah
- +2 more
Jan 15, 2020
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (Platelet Transfusion)
Terminated
- Acute Biphenotypic Leukemia
- +13 more
- Platelet Transfusion
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 17, 2019
Primary Myelofibrosis, MPN-associated Myelofibrosis Trial in Worldwide (Pomalidomide 0.5 mg, Placebo, Pomalidomide)
Completed
- Primary Myelofibrosis
- MPN-associated Myelofibrosis
- Pomalidomide 0.5 mg
- +2 more
-
Scottsdale, Arizona
- +86 more
Jun 24, 2019
Accelerated Phase Chronic Myelogenous Leukemia, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +178 more
- fludarabine phosphate
- +5 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Apr 17, 2017
Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +88 more
- palifermin
- +3 more
-
Seattle, WashingtonFred Hutchinson Cancer Research Center/University of Washington
Feb 19, 2014
Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic
Completed
- Accelerated Phase Chronic Myelogenous Leukemia
- +84 more
- sunitinib malate
- +2 more
-
Los Angeles, California
- +10 more
Mar 14, 2014